Fluorescence in situ hybridization aneuploidy as a predictor of clinical disease recurrence and prostate-specific antigen level 3 years after radical prostatectomy
James A. Brown, Jeffrey M. Slezak, Michael M. Lieber, Robert B. Jenkins
Dive into the research topics of 'Fluorescence in situ hybridization aneuploidy as a predictor of clinical disease recurrence and prostate-specific antigen level 3 years after radical prostatectomy'. Together they form a unique fingerprint.